Controlling meningococcal disease in 2017 - evidence from Australia, NZ and the UK - Friday 7 April 2017
Apr 2017 - Events
This one-day symposium organised by the National Centre for Immunisation Research and Surveillance, in partnership with the National Neisseria Network and the Communicable Diseases Network Australia was held on Friday 7 April 2017.
Meningococcal disease in Australia has increased from a nadir of 149 cases in 2013 to 253 cases in 2016, however this remains less than half the 688 cases notified in 2002. This increase has been driven by serogroups W and Y, which now account for >50% of cases. This workshop brought together national and international experts on meningococcal disease and heard the latest data from meningococcal B and ACWY vaccine programs in the United Kingdom. The workshop aimed to distill the best evidence to inform Australia’s response to meningococcal disease in 2017.
Resources from the Symposium
NB: Not all speakers were able to offer their presentation publicly as unpublished data was presented
PDFs of selected presentations are available from the following links. Please note files are large and may take a couple of minutes to download.
Trends in case numbers, age and serogroup specific incidence and mortality of invasive meningococcal disease in Australia 2001 - 2016 - Dr Jennie Hood
International context - by Prof. Peter McIntyre
New Zealand’s experience with starting and stopping meningococcal vaccine programs - Dr Amanda Kvalsvig
WA outbreak– lessons learned - Dr Paul Armstrong
Vaccine Safety Seminar - held on 29 October 2014
Oct 2014 - Events
This seminar brought together researchers, immunisation providers and public health staff interested in active surveillance for adverse events following immunisation (AEFI).
The focus of the seminar was to discuss and improve upon current methods of active and enhanced surveillance and to strengthen collaborative efforts across state, territory and national systems to improve vaccine safety surveillance.
Methods of active and enhanced surveillance, including solicited feedback via SMS, hospital-based surveillance for adverse events of special interest, and use of large health care databases; the role of the public and healthcare providers in AEFI surveillance and international models.
The opening address was provided by Prof Chris Baggoley, Chief Medical Officer, who gave an overview of vaccine safety surveillance in Australia in recent years.
International guest speaker Jennifer Nelson, PhD
Group Health Research Institute, University of Washington, Seattle, WA
National speakers included A/Prof Michael Gold (member of the Global Advisory Committee on Vaccine Safety of the WHO); Dr Jim Buttery (Director of SAEFVIC), Prof Paul Effler (WA Department of Health), Dr Alan Leeb (General Practitioner, WA) and Dr Tony Hobbs (Therapeutic Goods Administration)
PDFs of selected presentations given on the day are available via the individual links below. Please note files are large and may take a couple of minutes to download.
Overview of systems for active post-marketing surveillance in the USA AND Using large healthcare databases in the USA to assess vaccine safety - by Jennifer Nelson
What is active surveillance and how does this complement passive surveillance? - by Kristine Macartney
Why should we engage our patients in vaccine pharmacovigilance? Clinician researcher perspective - by Chris Blyth
Influenza vaccine safety surveillance in Western Australia - by Annette Regan
Vaxtracker: a web-based survey tool for vaccine safety - by Patrick Cashman
Going National: AusVaxSafety 2014 and beyond - by Gulam Khandaker
Hospital-based sentinel surveillance for AEFI - the PAEDS network - by Nick Wood
Sentinel site surveillance for rare complex conditions and the power of international collaboration - by Nigel Crawford
Can automated data from Emergency Department data collections help to assess vaccine safety - by Jim Buttery
GP encounter data to assess vaccine safety - by Rob Menzies
Click here for a PDF version of the program with speaker profiles
National Immunisation Program Implementation Seminar - held on 7 & 8 March 2013
Mar 2013 - Events
This one and a half day seminar brought together a range of key stakeholders involved in the development, management, delivery and evaluation of immunisation programs in Australia. Content included discussion around key implementation challenges and potential solutions with an aim to identifying priorities to enhance future immunisation program implementation in Australia.
The program featured invited speaker, Nikki Turner, from the New Zealand Immunisation Advisory Centre. Also featured were representatives from each state/territory immunisation program, Medicare Locals, immunisation providers including general practitioners and nurses, Aboriginal Community Controlled and remote health sectors.
Click here for a PDF version of the Immunisation Program Implementation Seminar booklet.
Click here to view presentations and panel discussions from the 2-day seminar.
Ethical Issues In Immunisation Seminar - held on 26 March 2012
Mar 2012 - Events
The Ethical Issues in Immunisation Seminar was held on March 26th, at The Darlington Centre, University of Sydney.
This 1-day seminar addressed the major ethical issues facing immunisation programs in Australia today:
* What level of vaccine risk is acceptable and who should decide?
* Is it unethical not to have a no-fault compensation scheme for serious adverse events attributed to vaccination?
* How far can we go in getting people to be vaccinated?
* Is the current system for funding vaccines sufficient?
* How can vaccine programs incorporate public values?
Speakers included Marie Bismark, Stacy Carter, Andrea Forde, Claire Hooker, David Isaacs, Heath Kelly, Ian Kerridge, Julie Leask, Kristine Macartney, Roger Magnusson, Helen Marshall, Peter Massey, Terry Nolan, Glenn Salkeld, Cameron Stewart.
PDFs of presentations given on the day are available via the links below. Please note files are large and may take a couple of minutes to download.
No-fault compensation for vaccine related injuries - the NZ experience - by Marie Bismark
How far can government go in promoting vaccination? - by Robert Hall
No fault compensation for adverse events attributed to vaccination - by Heath Kelly
A little bit more ethics on power and persuasion in immunisation - by Ian Kerridge
What is an acceptable risk and who decides? - by Roger Magnusson
Funding population immunisation in Australia - by Terry Nolan
An economic perspective on the selection and reimbursement of vaccines in Australia - by Glenn Salkeld
Legal arguments in favour of a vaccination compensation scheme - by Cameron Stewart
Click here for a PDF version of the Ethical Issues in Immunisation Seminar program
Workshop: Progress toward control of meningococcal disease - held on 15 November 2011
Nov 2011 - Events
Held on 15 November 2011 in Melbourne, this scientific workshop brought together national and international experts to share the latest information on the biology, epidemiology, prevention and complications of meningococcal disease.
National Pertussis Workshop - held on 25 & 26 August 2011
Aug 2011 - Events
Hosted by NCIRS on 25 and 26 August 2011 at Darling Harbour in Sydney, the National Pertussis workshop brought together national and international experts to share the latest information on pertussis. Topics included epidemiology, vaccine efficacy, vaccine schedules, new strategies and future steps and priorities on pertussis.
Click here for a PDF version of the National Pertussis Workshop program/abstract booklet
PDFs of presentations can be accessed via the presentation title links below. Please note files are large and may take a couple of minutes to download.
Day 1 - 25/8/2011
Is Australia the world capital of pertussis? - by Peter McIntyre
Pertussis control - has Canada got it right? - by Scott Halperin
Risk factors for death from pertussis (California)? - by Kath Harriman
Severity of pertussis in hospitalised children - by Helen Marshall
What do we know about source of infant infection? - by Kristine Macartney
Pertussis strains - do they matter? - by Ruiting Lan
Vaccine efficacy and surrogate markers - by Peter McIntyre
Vaccine effectiveness & duration of immunity - US overview - by Tom Clark
Vaccine effectiveness & duration of immunity - Australia - by Helen Quinn
What do we know about impact of vaccines on transmission? - by Patricia Campbell
Pertussis vaccine schedules - what can serosurveillance and modelling tell us - by Jodie McVernon
Day 2 - 26/8/2011
Experience with cocoon implementation and impact -
California - by Kath Harriman
US overview - by Tom Clark
Australia - by Stephen Lambert
Maternal immunisation - can we do it, what can we expect? - by Scott Halperin
Neonatal immunisation - can we do it, what can we expect? - by Nick Wood
Live attenuated pertussis vaccines - are they the future of pertussis control? - by Camille Locht
National meeting on pneumococcal disease (July 2009)
Jul 2009 - Events
PDFs of selected presentations available from links below:
Should Aboriginal children get both pneumococcal vaccines? - by Amanda Leach
How well is the 23vPPV working in the non-indigenous elderly? - by Rob Menzies
How well is the 23vPPV working in indigenous adults? - by Rob Menzies
Pneumococcal epidemiology in the conjugate vaccine era - can non-vaccine serotype replacement in carriage predict disease serotypes? - by Amanda Leach
PCR in pneumococcal disease diagnosis (and surveillance) - by Lyn Gilbert
Second Indigenous Immunisation Research Workshop (July 2009)
Jul 2009 - Events
PDFs of selected presentations are available from the links below:
A systems approach to improving immunisation timeliness - by Ross Bailie
NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation - by Terry Nolan
Immunisation Priorities for OATSIH - by Dr Geetha Isaac-Toua
Immunisation issues – ACCHS perspectives - by Jenny Hunt
Centre for Clinical Research Excellence in Aboriginal Health: Sexually transmitted and bloodborne viral infections - by James Ward
Estimates of hepatitis B infection - by Nick Wood
Universal paediatric influenza vaccination: the Western Australia experience - by Paul Effler
Immunisation of Indigenous people: Achievements and challenges - by Rob Menzies
Women, HPV, Indigenous, non-Indigenous Urban Rural Study - by Telphia Joseph
NCIRS Varicella Zoster Virus Workshop - held on 16 & 17 November 2006
Nov 2006 - Events
A 2-day workshop on the varicella-zoster virus was held in Sydney on the 16-17th November 2006. Prominent international guest speakers included Professor Myron Levin (US), Professor Anne Gershon (US) and Professor Judith Breuer (UK).